Genzyme Belgium zaventem

Company Info

Genzyme in Diegem

Genzyme Belgium operates all sales & marketing for the Belgium/Luxembourg (Belux) region in support of Genzyme’s therapies for lysosomal storage disorders and immune disease. The Belux team comprises 25 people, including product specialists, medical experts, as well as administrative and business managers.

Genzyme Belgium therapeutic areas

Lysosomal storage disorders

Lysosomal storage diseases are inherited metabolic diseases that are characterized by an abnormal build-up of various materials in the body's cells as a result of enzyme deficiencies. There are nearly 50 of these disorders altogether, and they may affect different parts of the body, including the skeleton, brain, skin, heart, and central nervous system. Therapies offered by Genzyme Belgium include enzyme replacement therapies for Gaucher disease, Fabry disease, MPS I (Hurler, Hurler-Scheie, and Scheie Syndromes) and Pompe disease. More information about Lysosomal storages diseases can be found on

Thyroid Cancer

Genzyme provides patients with an alternative to thyroid hormone withdrawal and the difficulties it can cause while giving doctors an effective follow-up tool in the management and in vivo diagnosis of well-differentiated thyroid cancer.

Contact Info:

Genzyme in Geel B.V.B.A./S.P.R.L.
Cipalstraat 8
B-2440 Geel
Tel: +32 14 564 911 (central/switchboard)
Fax: +32 14 564 916

Contact Info:

Genzyme Belgium Sales & Marketing
Airport Plaza - Montreal Building
Leonardo Da Vinci laan 19
B-1831 Diegem
Tel: +32 2 710 5400
Fax: +32 2 710 5409